“Preclinical studies consistently show the robust disease-modifying efficacy of intermittent fasting in animal models on a wide range of chronic disorders, including obesity, diabetes, cardiovascular disease, cancers, and neurodegenerative brain diseases,” notes a review paper on Intermittent fasting published in the New England Journal of Medicine.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.